JP6823321B2 - Bioabsorbable staple - Google Patents

Bioabsorbable staple Download PDF

Info

Publication number
JP6823321B2
JP6823321B2 JP2017544249A JP2017544249A JP6823321B2 JP 6823321 B2 JP6823321 B2 JP 6823321B2 JP 2017544249 A JP2017544249 A JP 2017544249A JP 2017544249 A JP2017544249 A JP 2017544249A JP 6823321 B2 JP6823321 B2 JP 6823321B2
Authority
JP
Japan
Prior art keywords
staple
erection
staples
photograph
connecting portion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017544249A
Other languages
Japanese (ja)
Other versions
JPWO2017061616A1 (en
Inventor
広夫 内田
広夫 内田
顕成 檜
顕成 檜
花田 幸太郎
幸太郎 花田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Institute of Advanced Industrial Science and Technology AIST
Tokai National Higher Education and Research System NUC
Original Assignee
National Institute of Advanced Industrial Science and Technology AIST
Tokai National Higher Education and Research System NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Institute of Advanced Industrial Science and Technology AIST, Tokai National Higher Education and Research System NUC filed Critical National Institute of Advanced Industrial Science and Technology AIST
Publication of JPWO2017061616A1 publication Critical patent/JPWO2017061616A1/en
Application granted granted Critical
Publication of JP6823321B2 publication Critical patent/JP6823321B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/064Surgical staples, i.e. penetrating the tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/08Wound clamps or clips, i.e. not or only partly penetrating the tissue ; Devices for bringing together the edges of a wound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters

Description

本発明は、生体吸収性ステープルに関し、特に、屈曲点を有さない形状とすることで、生体内に留置した際に、腐食による破断を起こり難くし、長期間にわたり縫合効果が得られるステープルに関する。 The present invention relates to a bioabsorbable staple, and particularly to a staple having a shape having no bending point, which makes it difficult for breakage due to corrosion to occur when placed in a living body and provides a suturing effect for a long period of time. ..

外科手術の際には、傷口を縫合する手段として糸が使用されてきたが、近年は、より早く且つ簡単に縫合することができ、更に、術後の縫合不全も手縫いと比較してほとんど変わらない手段として、ステープルが使用されている。ステープルは、皮膚、血管、腸管、骨や筋肉あるいは臓器等の様々な外科手術箇所で用いられている。また、体外から皮膚等に刺入れ縫合、或いは生体内で血管、腸管や臓器等を縫合した後に生体内に留置する等、縫合箇所に応じた方法で使用されている。 Threads have been used as a means of suturing wounds during surgery, but in recent years they can be sutured faster and easier, and postoperative suture failure is almost the same as hand-sewn. Staples are used as a non-existent means. Staples are used in various surgical sites such as skin, blood vessels, intestinal tract, bones, muscles or organs. Further, it is used by a method according to the sutured portion, such as piercing and suturing into the skin or the like from outside the body, or suturing a blood vessel, intestinal tract, organ or the like in the living body and then indwelling in the living body.

上記ステープルの内、生体内に留置するステープルとしては、ステンレス鋼、チタン、タンタル等の金属及び当該金属の表面にアモルファス状のダイヤモンド様のカーボン膜を形成した、ヒト体内において不溶性のステープルが知られている(特許文献1参照)。また、皮膚、筋膜または内部器官上の創傷を閉鎖するため、ヒト体内で可溶性の金属材料で作製したステープルも知られている(特許文献2参照)。 Among the above staples, as staples to be indwelled in a living body, metals such as stainless steel, titanium and tantalum, and staples insoluble in the human body in which an amorphous diamond-like carbon film is formed on the surface of the metal are known. (See Patent Document 1). Staples made of a metal material soluble in the human body for closing wounds on the skin, fascia or internal organs are also known (see Patent Document 2).

特開平5−154189号公報Japanese Unexamined Patent Publication No. 5-154189 特許第5036697号公報Japanese Patent No. 5036697

上記特許文献1及び2に記載されているとおり、生体内に留置するステープルとしては、生体内で不溶性及び可溶性の両方が知られている。ところで、不溶性の材料は生体にとって異物になることから、術後長期間にわたり不溶性の材料を生体内に留置した場合、難治性の感染症が起こる場合がある。そのため、生体内に留置するステープルとしては、生体内で可溶性の材料で作製することが望ましいと考えられる。しかしながら、実際の医療の現場では、生体内に留置するステープルはチタン等の不溶性の材料で作製されたものがほとんどで、可溶性の材料で作製したステープルは殆ど用いられていないという問題がある。 As described in Patent Documents 1 and 2, both insoluble and soluble staples in vivo are known as staples to be indwelled in vivo. By the way, since an insoluble material becomes a foreign substance to a living body, if the insoluble material is left in the living body for a long period after surgery, an intractable infectious disease may occur. Therefore, it is considered desirable that the staples to be indwelled in the living body are made of a material soluble in the living body. However, in the actual medical field, most of the staples to be indwelled in the living body are made of an insoluble material such as titanium, and there is a problem that staples made of a soluble material are rarely used.

本発明は、上記問題点を解決するためになされたもので、鋭意研究をおこなったところ、(1)生分解性の金属材料で作製したステープルを生体内に留置した場合、生体外から縫合した場合と異なり、ステープル全体が生体内成分により徐々に腐食する。その際に、ステープルの屈曲した箇所に生体組織を縫合するための力が集中するため、屈曲した箇所で破断し易くなること、(2)ステープルの2本の刺入部と縫合箇所を跨る架設部を連結するための連結部を、屈曲点を有しない湾曲部を含む形状に形成することで、生体組織を縫合するための力が分散されて特定箇所に力が集中しないため、ステープルが破断し難くなること、(3)架設部の少なくとも一部を、連結部の頂部と頂部を結んだ線より刺入部の先端側に位置するように形成することで、縫合箇所を2本の刺入部に加え架設部で押さえ付けることで縫合箇所を密着できること、を新たに見出した。 The present invention has been made to solve the above problems, and as a result of intensive research, (1) when staples made of a biodegradable metal material are placed in a living body, they are sutured from outside the living body. Unlike the case, the entire staple is gradually corroded by biodegradable components. At that time, since the force for suturing the living tissue is concentrated on the bent part of the staple, it is easy to break at the bent part, and (2) the erection straddling the two insertion parts of the staple and the sutured part. By forming the connecting part for connecting the parts into a shape including the curved part having no bending point, the force for suturing the living tissue is dispersed and the force is not concentrated at a specific place, so that the staple breaks. (3) By forming at least a part of the erection part so as to be located on the tip side of the insertion part from the line connecting the tops of the connection part, two stitches are stabbed. It was newly found that the sutured part can be brought into close contact by pressing with the erection part in addition to the entrance part.

すなわち、本発明の目的は、生体内に留置した際に、破断し難い生体吸収性ステープルを提供することにある。 That is, an object of the present invention is to provide a bioabsorbable staple that is hard to break when placed in a living body.

本発明は以下に示す生体吸収性ステープルに関する。 The present invention relates to the bioabsorbable staples shown below.

(1)生分解性金属材料で形成したステープルであって、
前記ステープルは、生体組織に刺し込む2本の刺入部、縫合箇所を跨る架設部、前記刺入部と前記架設部を連結する連結部を含み、
前記連結部は、屈曲点を有しない湾曲部を含む形状に形成され、且つ、
前記連結部の頂部と頂部を結んだ線より、前記架設部の少なくとも一部が刺入部の先端側に位置する生体吸収性ステープル。
(2)前記架設部の全てが、前記連結部の頂部と頂部を結んだ線より刺入部の先端側に位置する上記(1)に記載の生体吸収性ステープル。
(3)前記連結部のもっとも湾曲した部分が、曲率半径=0.275mm以上である上記(1)又は(2)に記載の生体吸収性ステープル。
(4)前記生分解性金属材料が、マグネシウムを主成分とする合金から選択される上記(1)〜(3)の何れか一に記載の生体吸収性ステープル。
(5)前記生分解性金属材料の周りが、生分解性樹脂でコーティングされている上記(1)〜(4)の何れか一に記載の生体吸収性ステープル。
(1) Staples made of biodegradable metal material
The staple includes two insertion portions to be inserted into a living tissue, an erection portion straddling a sutured portion, and a connecting portion connecting the insertion portion and the erection portion.
The connecting portion is formed in a shape including a curved portion having no bending point, and
A bioabsorbable staple in which at least a part of the erection portion is located on the tip side of the insertion portion from the line connecting the tops of the connection portion.
(2) The bioabsorbable staple according to (1) above, wherein all of the erection portions are located on the tip side of the insertion portion from the line connecting the tops of the connection portions.
(3) The bioabsorbable staple according to (1) or (2) above, wherein the most curved portion of the connecting portion has a radius of curvature of 0.275 mm or more.
(4) The bioabsorbable staple according to any one of (1) to (3) above, wherein the biodegradable metal material is selected from an alloy containing magnesium as a main component.
(5) The bioabsorbable staple according to any one of (1) to (4) above, wherein the biodegradable metal material is coated with a biodegradable resin.

生体吸収性ステープルの連結部は、屈曲点を有しない湾曲部を含む形状に形成されていることから、生体内に留置しても破断し難い。したがって、縫合箇所を長期間にわたり密着することができる。 Since the connecting portion of the bioabsorbable staple is formed in a shape including a curved portion having no bending point, it is difficult to break even if it is placed in a living body. Therefore, the sutured portion can be in close contact for a long period of time.

また、ステープルの連結部は屈曲点を有しない湾曲部を含む形状に形成されていることから、架設部の少なくとも一部を、連結部の頂部と頂部を結んだ線より刺入部の先端側に位置するように形成することができる。当該ステープルで縫合すると、縫合箇所を2本の刺入部に加え架設部で密着させることができるので、縫合箇所の密着効率を上げることができる。 Further, since the connecting portion of the staple is formed in a shape including a curved portion having no bending point, at least a part of the erection portion is on the tip side of the insertion portion from the line connecting the top and the top of the connecting portion. It can be formed to be located in. When sutured with the staple, the sutured portion can be brought into close contact with the erection portion in addition to the two insertion portions, so that the adhesion efficiency of the sutured portion can be improved.

図1は、ステープル1の実施形態の少なくとも一例を説明する図である。FIG. 1 is a diagram illustrating at least one example of an embodiment of staple 1. 図2は、「屈曲点」を説明するための図である。FIG. 2 is a diagram for explaining a “bending point”. 図3(A)〜(D)は、屈曲点を有しない湾曲部を含む形状の例を示す図である。3 (A) to 3 (D) are views showing an example of a shape including a curved portion having no bending point. 図4(A)〜(C)は、ステープル1の実施形態の他の例を示す図である。4 (A) to 4 (C) are views showing another example of the embodiment of staple 1. 図5(A)及び(B)はステープル1の実施形態に含まれない形状を示す図である。5 (A) and 5 (B) are views showing shapes not included in the embodiment of staple 1. 図6(A)及び(B)は、架設部3と連結部4との境界を説明する図で、図6(C)は、架設部3の他の例を示す図である。6 (A) and 6 (B) are diagrams for explaining the boundary between the erection portion 3 and the connecting portion 4, and FIG. 6 (C) is a diagram showing another example of the erection portion 3. 図7は、ステープル1の実施形態の更に他の例を示す図である。FIG. 7 is a diagram showing still another example of the embodiment of staple 1. 図8は、図面代用写真で、図8(A)は実施例1、図8(B)は実施例2、図8(C)は実施例3、図8(D)は実施例4、図8(E)は実施例5で、異なる直径(曲率半径)のステンレス製棒に線材を押し付けながら180°曲げた後の写真である。8 is a drawing substitute photograph, FIG. 8 (A) is Example 1, FIG. 8 (B) is Example 2, FIG. 8 (C) is Example 3, and FIG. 8 (D) is Example 4. 8 (E) is a photograph of Example 5 after bending 180 ° while pressing a wire rod against stainless steel rods having different diameters (radius of curvature). 図9は、図面代用写真で、図9(A)は実施例6で作製したステープルの写真、図9(B)は比較例1で作製したステープルの写真、図9(C)は腸管に穿刺した実施例6のステープルの写真、図9(D)は腸管に穿刺した比較例1のステープルの写真である。9 is a drawing substitute photograph, FIG. 9 (A) is a photograph of the staple prepared in Example 6, FIG. 9 (B) is a photograph of the staple prepared in Comparative Example 1, and FIG. 9 (C) is a puncture in the intestinal tract. A photograph of the staple of Example 6 and FIG. 9 (D) is a photograph of the staple of Comparative Example 1 punctured in the intestinal tract. 図10は、図面代用写真で、図10(A)は実施例7の術後1週間のHE染色した切片の写真(20倍拡大)、図10(B)は実施例7の術後1週間のHE染色した切片の写真(200倍拡大)である。図10(C)は比較例2の術後1週間のHE染色した切片の写真(20倍拡大)、図10(D)は比較例2の術後1週間のHE染色した切片の写真(200倍拡大)である。10 (A) is a drawing substitute photograph, FIG. 10 (A) is a photograph of a HE-stained section of Example 7 one week after the operation (magnified 20 times), and FIG. 10 (B) is one week after the operation of Example 7. It is a photograph (200 times magnification) of the HE-stained section of. FIG. 10 (C) is a photograph of the HE-stained section of Comparative Example 2 one week after the operation (magnified 20 times), and FIG. 10 (D) is a photograph of the HE-stained section of Comparative Example 2 one week after the operation (200). Double magnification). 図11は、図面代用写真で、図11(A)は実施例7の術後2週間のHE染色した切片の写真(40倍拡大)、図11(B)は実施例7の術後2週間のHE染色した切片の写真(100倍拡大)である。図11(C)は比較例2の術後2週間のHE染色した切片の写真(40倍拡大)、図11(D)は比較例2の術後2週間のHE染色した切片の写真(100倍拡大)である。FIG. 11 is a drawing-substituting photograph, FIG. 11 (A) is a photograph of a HE-stained section 2 weeks after the operation of Example 7 (magnified 40 times), and FIG. 11 (B) is a photograph 2 weeks after the operation of Example 7. It is a photograph (100 times magnification) of the section which was stained with HE. FIG. 11 (C) is a photograph of the HE-stained section of Comparative Example 2 2 weeks after the operation (magnified 40 times), and FIG. 11 (D) is a photograph of the HE-stained section of Comparative Example 2 2 weeks after the operation (100). Double magnification). 図12は、図面代用写真で、図12(A)は実施例7の術後4週間のHE染色した切片の写真(100倍拡大)、図12(B)は実施例7の術後4週間のHE染色した切片の写真(400倍拡大)である。図12(C)は比較例2の術後4週間のHE染色した切片の写真(100倍拡大)、図12(D)は比較例2の術後4週間のHE染色した切片の写真(400倍拡大)である。12A and 12B are photographs of substitute drawings, FIG. 12A is a photograph of a HE-stained section of Example 7 4 weeks after the operation (enlarged 100 times), and FIG. 12B is a photograph of the section 4 weeks after the operation of Example 7. It is a photograph (400 times magnification) of the section which was stained with HE. FIG. 12 (C) is a photograph (100-fold magnification) of the HE-stained section of Comparative Example 2 4 weeks after the operation, and FIG. 12 (D) is a photograph (400) of the HE-stained section of Comparative Example 2 4 weeks after the operation. Double magnification).

以下に、ステープルの実施形態について詳しく説明する。図1は、ステープルの実施形態の一例を説明する図である。図1に示すステープル1は、外科手術等により縫合が必要な箇所の生体組織に刺し込む2本の刺入部2、縫合箇所を跨る架設部3、刺入部2と架設部3を連結する2つの連結部4を含んでいる。 The embodiments of staples will be described in detail below. FIG. 1 is a diagram illustrating an example of an embodiment of staples. The staple 1 shown in FIG. 1 connects two puncture portions 2, an erection portion 3 straddling the suture portion, and the puncture portion 2 and the erection portion 3 to be pierced into a biological tissue at a portion requiring suturing by surgery or the like. Includes two connecting parts 4.

連結部4は、屈曲点を有しない湾曲部を含む形状に形成されている。なお、本願において「屈曲点」とは、図2に示すように、線材を特定の箇所を中心に折り曲げた際の折り曲げ中心箇所5を意味し、折り曲げ中心箇所5を有しない滑らかな局面が続く湾曲部とは異なる。本願では、「屈曲点」を含まないことから、縫合箇所を密着するための力がステープルの特定箇所に集中し難くなり、その結果、生体内で腐食作用を受けても破断し難くなる。 The connecting portion 4 is formed in a shape including a curved portion having no bending point. In the present application, as shown in FIG. 2, the “bending point” means a bending center portion 5 when the wire rod is bent around a specific portion, and a smooth phase having no bending center portion 5 continues. It is different from the curved part. In the present application, since the "bending point" is not included, it becomes difficult for the force for adhering the sutured portion to concentrate on the specific portion of the staple, and as a result, it becomes difficult to break even if it is corroded in the living body.

また、本願の「屈曲点を有しない湾曲部を含む形状」とは、屈曲点を含まず、且つ、湾曲部を含むことで刺入部2と架設部3とを連結することができる全ての形状を意味する。例えば、図3(A)に示すように、連結部4の全体が滑らかに連続して同一方向に湾曲している形状、図3(B)に示すように、連結部4の一部又は全部が波状部分を含み、連結部4が全体としては同一方向に湾曲している形状、図3(C)に示すように、連結部4が直線部分と湾曲部分を含んでいる形状が挙げられる。なお、図示は省略するが、図3(B)に示す形状の連結部4の一部に直線部分を含んでいてもよい。また、図3(A)〜(C)に示す形状の連結部4は、刺入部2からステープル1の内側方向に徐々に湾曲しているが、図3(D)に示すように、刺入部2からステープル1の外側方向に先ず湾曲し、次いで、ステープル1の内側方向に徐々に湾曲するようにしてもよい。また、図示は省略するが、図3(D)に示す形状の連結部4の場合も、図3(B)に示すように一部又は全部が波状部分、図3(C)に示すような直線部分を含んでいてもよい。なお、図3は、本願のステープル1の具体的形状の例示であって、図3に示す例に限定されるものではない。「屈曲点を有しない湾曲部を含む形状」であれば、図示しない形状であってもよい。 Further, the "shape including a curved portion having no bending point" in the present application means all cases in which the insertion portion 2 and the erection portion 3 can be connected by including the curved portion without including the bending point. Means shape. For example, as shown in FIG. 3A, the entire connecting portion 4 is smoothly and continuously curved in the same direction, and as shown in FIG. 3B, a part or all of the connecting portion 4 is formed. There is a shape in which the connecting portion 4 includes a wavy portion and the connecting portion 4 is curved in the same direction as a whole, and a shape in which the connecting portion 4 includes a straight portion and a curved portion as shown in FIG. 3C. Although not shown, a straight line portion may be included in a part of the connecting portion 4 having the shape shown in FIG. 3 (B). Further, the connecting portion 4 having a shape shown in FIGS. 3A to 3C is gradually curved from the insertion portion 2 toward the inside of the staple 1, but as shown in FIG. 3D, the insertion portion 4 is inserted. It may be curved from the inlet 2 toward the outside of the staple 1 first, and then gradually curved toward the inside of the staple 1. Further, although not shown, in the case of the connecting portion 4 having the shape shown in FIG. 3 (D), a part or the whole is a wavy portion as shown in FIG. 3 (B), as shown in FIG. 3 (C). It may include a straight line portion. Note that FIG. 3 is an example of the specific shape of the staple 1 of the present application, and is not limited to the example shown in FIG. A shape (not shown) may be used as long as it is a "shape including a curved portion having no bending point".

なお、実施形態に係るステープル1は、ステープラーのカートリッジに入れ、ステープル1を押し出して生体組織に穿刺する。図3(D)に示す形状のステープル1も使用可能ではあるが、連結部4がステープル1の外側にせり出していると、刺入部2がカートリッジの壁面から離れてしまう。そのため、穿刺時の安定性との観点からは、図3(A)〜(C)に示すように、連結部4が刺入部2からステープル1の内側方向に徐々に湾曲している形状の方が好ましい。 The staple 1 according to the embodiment is placed in a stapler cartridge, and the staple 1 is extruded and punctured into a living tissue. Although the staple 1 having the shape shown in FIG. 3D can be used, if the connecting portion 4 protrudes to the outside of the staple 1, the insertion portion 2 is separated from the wall surface of the cartridge. Therefore, from the viewpoint of stability during puncture, as shown in FIGS. 3A to 3C, the connecting portion 4 has a shape in which the connecting portion 4 is gradually curved inward from the puncturing portion 2 to the staple 1. Is preferable.

架設部3は、一方の連結部4の頂部41及び他方の連結部4の頂部41を結んだ線(図1中の点線)より、少なくとも一部が刺入部2の先端21側に位置している。なお、本願において、「頂部」とは、図1に示すとおり、刺入部2の2つの先端21を結んだ線から最も距離Hがある箇所を意味する。 At least a part of the erection portion 3 is located on the tip 21 side of the insertion portion 2 from the line connecting the top 41 of one connecting portion 4 and the top 41 of the other connecting portion 4 (dotted line in FIG. 1). ing. In the present application, as shown in FIG. 1, the “top” means a portion having the longest distance H from the line connecting the two tips 21 of the insertion portion 2.

図1は、架設部3の全てが頂部41と頂部41を結んだ線より刺入部2の先端21側に位置している例を示しているが、上記の架設部3と頂部41の位置関係を満たせば特に制限は無い。図4は、ステープル1の実施形態の他の例を示しており、図4(A)は架設部3を波形状で形成し、波の一つが頂部41を結んだ線より先端21とは反対側に突出、図4(B)は架設部3を波形状で形成し、波の全てが頂部41を結んだ線より先端21側に突出、図4(C)は架設部3を波形状で形成し、複数の波が頂部41を結んだ線より先端21とは反対側に突出、している例を示している。架設部3の形状は、縫合する箇所の形状に応じて適宜決めればよい。 FIG. 1 shows an example in which all of the erection portion 3 is located on the tip 21 side of the insertion portion 2 from the line connecting the top portion 41 and the top portion 41, but the positions of the above-mentioned erection portion 3 and the top portion 41 are shown. There are no particular restrictions as long as the relationship is satisfied. FIG. 4 shows another example of the embodiment of staple 1, in FIG. 4 (A), the erection portion 3 is formed in a wave shape, and one of the waves is opposite to the tip 21 from the line connecting the top 41. Projected to the side, FIG. 4 (B) forms the erection portion 3 in a wavy shape, all of the waves project toward the tip 21 side from the line connecting the tops 41, and FIG. 4 (C) shows the erection portion 3 in a wavy shape. An example is shown in which a plurality of waves are formed and protrude from the line connecting the top 41 to the side opposite to the tip 21. The shape of the erection portion 3 may be appropriately determined according to the shape of the portion to be sewn.

また、図5は、ステープル1の実施形態に含まれない例を示している。当該技術分野においては、図5(A)に示す略U字型や、図5(B)に示す略コ字状のステープルが知られている。しかしながら、図5(A)及び(B)に示す形状のステープルは、連結部4の頂部41と頂部41を結んだ線より、架設部3のいずれの部分も刺入部2の先端21側に位置していないことから、ステープル1の実施形態には含まれない。 Further, FIG. 5 shows an example not included in the embodiment of staple 1. In the art, the substantially U-shaped staples shown in FIG. 5 (A) and the substantially U-shaped staples shown in FIG. 5 (B) are known. However, in the staples having the shapes shown in FIGS. 5A and 5B, any part of the erection portion 3 is on the tip 21 side of the insertion portion 2 from the line connecting the top portions 41 and the top portions 41 of the connecting portion 4. Since it is not located, it is not included in the embodiment of staple 1.

図6は、架設部3と連結部4との境界を説明する図である。図6(A)に示すように、連結部4の全体が滑らかに同一方向に湾曲している場合、連結部4の任意の2点を円弧とする仮想円の中心点Rは、何れもステープル1の内側になる。連結部4が直線部分を含んでいる場合でも、Rがステープル1の外側になることは無い。一方、架設部3の一部は、頂部41と頂部41を結んだ線より先端21側にあるため、任意の2点を円弧とする仮想円の中心点Rはステープル1の外側になる部分がある。架橋部3と連結部4との境界は、円弧の中心点が反転する箇所と定義すればよい。一方、図6(B)に示すように、連結部4が波状部分を含む場合、仮想円の中心点Rはステープル1の内側及び外側の両方に位置する。その場合、円弧の中心点がステープル1の内側から外側に反転する最後の箇所を架設部3と連結部4との境界と定義すればよい。なお、架設部3と連結部4との境界は上記のように定義されるので、例えば、図6(C)に示すように、架設部3が略U字状の形状もステープル1の実施形態に含まれる。 FIG. 6 is a diagram illustrating a boundary between the erection portion 3 and the connecting portion 4. As shown in FIG. 6A, when the entire connecting portion 4 is smoothly curved in the same direction, the center points R of the virtual circle having any two points of the connecting portion 4 as arcs are staples. It will be inside 1. Even when the connecting portion 4 includes a straight portion, R does not become outside the staple 1. On the other hand, since a part of the erection portion 3 is on the tip 21 side of the line connecting the top 41 and the top 41, the center point R of the virtual circle having any two points as an arc is the portion outside the staple 1. is there. The boundary between the bridging portion 3 and the connecting portion 4 may be defined as a location where the center point of the arc is inverted. On the other hand, as shown in FIG. 6B, when the connecting portion 4 includes the wavy portion, the center point R of the virtual circle is located both inside and outside the staple 1. In that case, the last point where the center point of the arc is inverted from the inside to the outside of the staple 1 may be defined as the boundary between the erection portion 3 and the connecting portion 4. Since the boundary between the erection portion 3 and the connecting portion 4 is defined as described above, for example, as shown in FIG. 6C, the erection portion 3 has a substantially U-shaped shape according to the embodiment of the staple 1. include.

図7は、ステープル1の実施形態の更に他の例を示している。ステープル1の刺入部2は、生体組織に穿刺し易くするため、ほぼ直線状となっている。そのため、刺入部2を穿刺した後に連結部4が生体組織に当接すると、ステープル1がほぼ直線から徐々に曲がるためステープル1を生体組織に穿刺し難くなる。そのため、図7に示すように、架設部3の少なくとも一部を、連結部4の頂部41と頂部41を結んだ線より更に刺入部2の先端21側である刺入部2と連結部4の境界24を結んだ線25より刺入部2の先端21側に位置するように形成してもよい。図7に示す実施形態の場合、架設部3が縫合箇所により当接し易くなることから、縫合箇所の密着効率を上げることができる。刺入部2と連結部4との境界は、刺入部2が湾曲し始める場所とすればよい。 FIG. 7 shows yet another example of the staple 1 embodiment. The puncture portion 2 of the staple 1 is substantially linear in order to facilitate puncture into the living tissue. Therefore, when the connecting portion 4 comes into contact with the living tissue after the puncture portion 2 is punctured, the staple 1 gradually bends from a substantially straight line, making it difficult to puncture the staple 1 into the living tissue. Therefore, as shown in FIG. 7, at least a part of the erection portion 3 is connected to the insertion portion 2 which is the tip 21 side of the insertion portion 2 further than the line connecting the top 41 and the top 41 of the connection portion 4. It may be formed so as to be located on the tip 21 side of the insertion portion 2 from the line 25 connecting the boundary 24 of 4. In the case of the embodiment shown in FIG. 7, since the erection portion 3 is more likely to come into contact with the sewn portion, the adhesion efficiency of the sewn portion can be improved. The boundary between the insertion portion 2 and the connecting portion 4 may be a place where the insertion portion 2 begins to bend.

上記のとおり、各々の実施形態に示すステープル1は、屈曲点を有さないことを特徴としているが、ステープル1の特定箇所に負荷がかからないようにするためには、湾曲部の曲率半径を大きくすることが好ましい。なお、本願において「曲率半径」とは、連結部4の湾曲部の任意の2点を円弧とする仮想円の半径を意味する。連結部4の曲率半径は、0.1mm以上が好ましく、0.275mm以上がより好ましく、0.4mm以上が更に好ましい。また、連結部4と架設部3、連結部4と刺入部2との境界部分についても、上記と同様の曲率半径とすることが好ましい。連結部4を波形状にする場合は、上記の曲率半径となるように、振幅を小さくすればよい。なお、架設部3を波形状とする場合も、上記と同様の曲率半径となるようにすればよい。 As described above, the staple 1 shown in each embodiment is characterized in that it does not have a bending point, but in order to prevent a load from being applied to a specific portion of the staple 1, the radius of curvature of the curved portion is increased. It is preferable to do so. In the present application, the "radius of curvature" means the radius of a virtual circle having an arc at any two points of the curved portion of the connecting portion 4. The radius of curvature of the connecting portion 4 is preferably 0.1 mm or more, more preferably 0.275 mm or more, still more preferably 0.4 mm or more. Further, it is preferable that the boundary portion between the connecting portion 4 and the erection portion 3 and the connecting portion 4 and the insertion portion 2 has the same radius of curvature as described above. When the connecting portion 4 has a wavy shape, the amplitude may be reduced so as to have the above-mentioned radius of curvature. Even when the erection portion 3 has a wavy shape, the radius of curvature may be the same as described above.

また、各々の実施形態に示すステープル1が用いられる縫合箇所に特に制限は無く、縫合箇所の厚み等に応じた大きさのステープルを用いればよい。ステープル1の大きさは、例えば、縦幅(刺入部2の先端から架設部3の距離)が2〜5mm(生体組織に穿刺した後の縦幅は0.5mm〜3mm)、横幅(刺入部2と刺入部2との間隔)が1mm〜5mm程度のものが例示できるが、上記のとおり、サイズについては、縫合箇所に応じて適宜調整すればよい。 Further, there is no particular limitation on the stitched portion where the staple 1 shown in each embodiment is used, and a staple having a size corresponding to the thickness or the like of the stitched portion may be used. The size of the staple 1 is, for example, a vertical width (distance from the tip of the insertion portion 2 to the erection portion 3) of 2 to 5 mm (the vertical width after puncturing the living tissue is 0.5 mm to 3 mm) and a horizontal width (stab). The distance between the insertion portion 2 and the insertion portion 2) can be exemplified by about 1 mm to 5 mm, but as described above, the size may be appropriately adjusted according to the stitched portion.

各々の実施形態に示すステープル1は、生体内に留置した際に生分解する金属材料であれば、特に制限は無い。例えば、生分解性金属材料としては、純マグネシウムまたはマグネシウム合金、純カルシウムまたはカルシウム合金、純亜鉛または亜鉛合金などが使用される。好ましくは、純マグネシウムまたはマグネシウム合金である。マグネシウム合金としては、マグネシウムを主成分とし、H、C、N、O、Na、P、K、Ca、Fe、B、Al、Si、V、Cr、Mn、Znからなる体内必須元素、もしくはSc、Y、La、Ce、Nd、Sm、Gd、Tb、Dy、Ybからなる希土類元素から選択される少なくとも1つの元素を含有するものが好ましい。 The staple 1 shown in each embodiment is not particularly limited as long as it is a metal material that biodegrades when placed in a living body. For example, as the biodegradable metal material, pure magnesium or magnesium alloy, pure calcium or calcium alloy, pure zinc or zinc alloy and the like are used. A pure magnesium or magnesium alloy is preferred. The magnesium alloy contains magnesium as a main component and is an essential element in the body composed of H, C, N, O, Na, P, K, Ca, Fe, B, Al, Si, V, Cr, Mn, Zn, or Sc. , Y, La, Ce, Nd, Sm, Gd, Tb, Dy, Yb, preferably containing at least one element selected from rare earth elements.

また、各々の実施形態に示すステープル1は、生分解性金属材料のみで作製してもよいが、生分解性金属材料の周りを、生分解性樹脂でコーティングしてもよい。生分解性樹脂でコーティングすることで、生体内に留置した際のステープル1の腐食の進行を調整することができる。生分解性樹脂としては、生体内で酵素的、非酵素的に分解され、分解物が毒性を示さないものであれば特に限定されない。例えば、ポリ乳酸、ポリグリコール酸、ポリ乳酸−ポリグリコール酸共重合体、ポリカプロラクトン、ポリ乳酸−ポリカプロラクトン共重合体、ポリオルソエステル、ポリホスファゼン、ポリリン酸エステル、ポリヒドロキシ酪酸、ポリリンゴ酸、ポリα−アミノ酸、コラーゲン、ゼラチン、ラミニン、ヘパラン硫酸、フィブロネクチン、ビトロネクチン、コンドロイチン硫酸、ヒアルロン酸、ポリヒドロキシブチレイト吉草酸、ポリサリチル酸、ポリペプチド、多糖類、キチン、キトサンなどが挙げられる。 Further, the staple 1 shown in each embodiment may be made of only a biodegradable metal material, or the periphery of the biodegradable metal material may be coated with a biodegradable resin. By coating with a biodegradable resin, the progress of corrosion of staple 1 when placed in a living body can be adjusted. The biodegradable resin is not particularly limited as long as it is enzymatically or non-enzymatically decomposed in a living body and the decomposed product does not show toxicity. For example, polylactic acid, polyglycolic acid, polylactic acid-polyglycolic acid copolymer, polycaprolactone, polylactic acid-polycaprolactone copolymer, polyorthoester, polyphosphazene, polyphosphate ester, polyhydroxybutyrate, polyapple acid, poly. Examples thereof include α-amino acids, collagen, gelatin, laminin, heparan sulfate, fibronectin, bitronectin, chondroitin sulfate, hyaluronic acid, polyhydroxybutyrate valeric acid, polysalicylic acid, polypeptides, polysaccharides, chitin and chitosan.

また、生分解性金属材料、又は生分解性金属材料をコーティングしている生分解性樹脂は、生理活性物質を担持しているものであってもよい。生理活性物質は、生分解性金属材料又は生分解性樹脂の表面に担持されていれば特に制限は無く、例えば、生理活性物質を溶剤等に溶解し、塗布すればよい。 Further, the biodegradable metal material or the biodegradable resin coated with the biodegradable metal material may carry a physiologically active substance. The physiologically active substance is not particularly limited as long as it is supported on the surface of a biodegradable metal material or a biodegradable resin. For example, the physiologically active substance may be dissolved in a solvent or the like and applied.

生理活性物質としては、治療等に用いられている公知の医薬品であれば特に制限は無い。例えば、体内に留置するステープルは生体にとっては異物であるため、抗炎症剤、抗生物質、抗アレルギー剤等を担持することで、術後の炎症等を抑制することができる。また、縫合箇所が血管であれば止血剤等、縫合箇所が癌であれば抗がん剤等を担持してもよい。 The physiologically active substance is not particularly limited as long as it is a known drug used for treatment or the like. For example, since staples placed in the body are foreign substances to the living body, postoperative inflammation and the like can be suppressed by carrying an anti-inflammatory agent, an antibiotic, an antiallergic agent and the like. Further, if the sutured part is a blood vessel, a hemostatic agent or the like may be carried, and if the sutured part is cancer, an anticancer agent or the like may be carried.

各々の実施形態に示すステープル1は、上記のとおり、連結部4が屈曲点を有しない湾曲部を含む形状に形成されていれば、製造方法は特に制限は無い。例えば、少なくとも連結部4及び架設部3の形状に対応した金型を作製し、生分解性金属材料で作製した薄板をプレス成型すればよい。又は、刺入部2、連結部4及び架設部3の形状の金型を作製し、溶融した生分解性金属材料を射出成形すればよい。なお、刺入部2の先端部分は、生体組織に穿刺し易くするためにテーパー状にしてもよい。先端をテーパー状にするためには、プレスや射出成形用の鋳型を調整、又はプレス等で作製したステープをせん断もしくは研削すればよい。 As described above, the staple 1 shown in each embodiment is not particularly limited in the manufacturing method as long as the connecting portion 4 is formed in a shape including a curved portion having no bending point. For example, a mold corresponding to at least the shapes of the connecting portion 4 and the erection portion 3 may be produced, and a thin plate made of a biodegradable metal material may be press-molded. Alternatively, a mold having the shape of the insertion portion 2, the connecting portion 4, and the erection portion 3 may be produced, and the melted biodegradable metal material may be injection-molded. The tip portion of the insertion portion 2 may be tapered in order to facilitate puncture into the living tissue. In order to taper the tip, a mold for pressing or injection molding may be adjusted, or a stap made by pressing or the like may be sheared or ground.

各々の実施形態に示すステープル1は、公知の生体組織用のステープラーのカートリッジにセットして用いればよい。なお、各々の実施形態に示すステープル1は、連結部4が架設部3より刺入部2の先端側に位置しているため、カートリッジの連結部4に当接する部分が直線形状であると連結部の少なくとも一部は当該部分から離れることになる。そのため、ステープラーのステープルを押圧する部分が従来のコ字状のものを用いると、連結部4の頂部41に押圧力が集中してしまう恐れがある。そのため、各々の実施形態に示すステープル1を用いるステープラーの押圧部は、連結部4と架設部3に適合する形状とすることが好ましい。 The staple 1 shown in each embodiment may be used by being set in a known stapler cartridge for living tissue. In the staple 1 shown in each embodiment, since the connecting portion 4 is located closer to the tip end side of the insertion portion 2 than the erection portion 3, the staple 1 is connected when the portion abutting on the connecting portion 4 of the cartridge has a linear shape. At least a part of the part will be separated from the part. Therefore, if a conventional U-shaped portion for pressing the stapler of the stapler is used, the pressing force may be concentrated on the top 41 of the connecting portion 4. Therefore, it is preferable that the pressing portion of the stapler using the staple 1 shown in each embodiment has a shape suitable for the connecting portion 4 and the erection portion 3.

以下に実施例を掲げ、実施形態を具体的に説明するが、この実施例は単にその具体的な態様の参考のために提供されているものである。これらの例示は本願のステープル1の実施形態の特定の具体的な態様を説明するためのものであるが、本願で開示する実施形態の範囲を限定したり、あるいは制限することを表すものではない。 An embodiment will be specifically described below with reference to the embodiment, but the embodiment is provided merely as a reference for the specific embodiment. These examples are for explaining specific specific embodiments of the staple 1 embodiment of the present application, but do not represent limiting or limiting the scope of the embodiments disclosed in the present application. ..

<実施例1〜5>
[合金線材の作製]
マグネシウム(Mg)、ネオジウム(Nd)、イットリウム(Y)及びジルコニウム(Zr)を、重量%で95.6%Mg−3.0%Nd−1.0%Y−0.4%Zrとなるように、それぞれの純金属を高周波誘導加熱用グラファイト坩堝に入れ、高周波溶解炉チャンバー内の高周波コイル内部に設置した。次に、チャンバー内を真空引きした後、大気圧になるまでヘリウムガスを充填し、坩堝を750℃まで加熱し、坩堝内の金属が全て溶融するのを確認した上で10分間保持し、その後、直ちに坩堝内の溶融物を予め高周波コイルの前面に設置しておいた円柱タイプの銅製鋳型に鋳込んだ。一定時間冷却した後、この鋳型から円柱状の上記合金インゴットを得た。
<Examples 1 to 5>
[Making alloy wire]
Magnesium (Mg), Neodium (Nd), Yttrium (Y) and Zirconium (Zr) are added to 95.6% Mg-3.0% Nd-1.0% Y-0.4% Zr by weight. Each pure metal was placed in a graphite crucible for high frequency induction heating and installed inside the high frequency coil in the high frequency melting furnace chamber. Next, after evacuating the inside of the chamber, it is filled with helium gas until it reaches atmospheric pressure, the crucible is heated to 750 ° C., and after confirming that all the metal in the crucible is melted, it is held for 10 minutes, and then held. Immediately, the melt in the crucible was cast into a cylindrical type copper mold previously installed in front of the high frequency coil. After cooling for a certain period of time, a columnar alloy ingot was obtained from this mold.

得られた合金インゴットは、温度400℃、押出し比15、押出し速度60mm/minの条件で熱間押出し成形し、外径17mmの棒材となるように加工した。そして、この合金棒材からビレット(外径10mm×長さ25mm)を切り出し、温度400℃、押出し比28の条件で熱間押出し成形を行い外径1.9mmの合金線材を得た。 The obtained alloy ingot was hot-extruded under the conditions of a temperature of 400 ° C., an extrusion ratio of 15, and an extrusion speed of 60 mm / min, and processed into a bar having an outer diameter of 17 mm. Then, a billet (outer diameter 10 mm × length 25 mm) was cut out from this alloy rod and hot-extruded under the conditions of a temperature of 400 ° C. and an extrusion ratio of 28 to obtain an alloy wire having an outer diameter of 1.9 mm.

次に、合金線材を引き抜きダイスに挿入し、常温で引抜き加工を行った。引抜き加工の前後の合金線断面の減面率は30%以下となるように調整し、引抜き加工後には400℃×30minの焼鈍を行った。そして、合金線材の線径が0.25mmになるまで、引抜き加工、焼鈍を繰り返し行った。 Next, the alloy wire was inserted into a drawing die and drawn at room temperature. The surface reduction rate of the cross section of the alloy wire before and after the drawing process was adjusted to be 30% or less, and after the drawing process, annealing was performed at 400 ° C. for 30 minutes. Then, drawing and annealing were repeated until the wire diameter of the alloy wire became 0.25 mm.

得られた線径0.25mmの合金線材を長さ25mmに切断し、以下の直径(曲率半径)のステンレス製棒に押し付けながら180°曲げた。
・実施例1:直径0.2mm(曲率半径=0.1mm)
・実施例2:直径0.55mm(曲率半径=0.275mm)
・実施例3:直径0.8mm(曲率半径=0.4mm)
・実施例4:直径1.0mm(曲率半径=0.5mm)
・実施例5:直径1.5mm(曲率半径=0.75mm)
The obtained alloy wire having a diameter of 0.25 mm was cut to a length of 25 mm and bent 180 ° while being pressed against a stainless steel rod having the following diameter (radius of curvature).
Example 1: Diameter 0.2 mm (radius of curvature = 0.1 mm)
Example 2: Diameter 0.55 mm (radius of curvature = 0.275 mm)
Example 3: Diameter 0.8 mm (radius of curvature = 0.4 mm)
Example 4: Diameter 1.0 mm (radius of curvature = 0.5 mm)
Example 5: Diameter 1.5 mm (radius of curvature = 0.75 mm)

図8(A)は実施例1、図8(B)は実施例2、図8(C)は実施例3、図8(D)は実施例4、図8(E)は実施例5で、180°曲げた後の写真である。なお、試料は各々3本作製して、上記の曲率半径で曲げた。表1に示すように、180°曲げた際に、実施例1の試料(合金線材)は曲げ加工部に亀裂が認められたが(破断はしていない)、実施例2〜5の試料は曲げ加工部に亀裂は認められなかった。 8 (A) is Example 1, FIG. 8 (B) is Example 2, FIG. 8 (C) is Example 3, FIG. 8 (D) is Example 4, and FIG. 8 (E) is Example 5. , It is a photograph after bending 180 °. Three samples were prepared and bent at the above-mentioned radius of curvature. As shown in Table 1, when the sample (alloy wire rod) of Example 1 was bent by 180 °, a crack was observed in the bent portion (not broken), but the samples of Examples 2 to 5 were found. No cracks were found in the bent part.

[浸漬実験]
次に、生体内を模した浸漬実験系を作製し、実施例1〜5の試料を浸漬実験系に浸漬した際の腐食変化について調べた。
先ず、実施例1〜5の試料を、0.5%硝酸水溶液に20秒間浸漬し、酸洗浄を行った後、純水、アセトンの順で超音波洗浄を各1分間施し、乾燥した。
次に、牛血清(ニュージーランド産;Thermo Fisher Scientific社製Gibco)10mlを試験管に入れて浸漬実験系を作製した。そして、上記処理を施した試料を試験管に入れ、37℃に保たれた恒温槽内で試験管を保持し、浸漬時間3、6、9hで腐食状態を観察した。結果を表1に示す。浸漬時間が進むにつれ曲げ部での腐食破断が生じ、曲率半径が小さくなるほどその傾向が強く見受けられた。しかしながら、曲率半径=0.4mm以上では特に大きな差は見受けられなかった。
[Immersion experiment]
Next, an immersion experimental system imitating the inside of a living body was prepared, and the corrosion change when the samples of Examples 1 to 5 were immersed in the immersion experimental system was investigated.
First, the samples of Examples 1 to 5 were immersed in a 0.5% aqueous nitric acid solution for 20 seconds, acid-cleaned, and then ultrasonic-cleaned in the order of pure water and acetone for 1 minute each and dried.
Next, 10 ml of bovine serum (from New Zealand; Gibco manufactured by Thermo Fisher Scientific) was placed in a test tube to prepare an immersion experimental system. Then, the sample subjected to the above treatment was placed in a test tube, the test tube was held in a constant temperature bath kept at 37 ° C., and the corrosion state was observed at immersion times 3, 6 and 9 hours. The results are shown in Table 1. Corrosion fracture occurred at the bent portion as the immersion time progressed, and this tendency was more strongly observed as the radius of curvature became smaller. However, no significant difference was observed when the radius of curvature was 0.4 mm or more.

[穿刺実験]
<実施例6>
上記実施例1〜5に記載と同様の手順で得られた線径0.25mmの合金線材を、プレス加工により3mm(左右の刺入部2と連結部4の境界24を結んだ距離)×2.5mm(刺入部2と連結部4の頂部41までの長さ)のステープル形状に加工した。ステープルの刺入部2の先端は、刺入方向に対しステープル内側に向かって45度の角度でテーパー加工を施した。また、連結部4の曲率半径は0.5mmとした。架設部3の長さは2.5mmであった。次に、直径0.5mmのステンレス製棒を加工したステープルの架設部3に押付けることによって、架設部4が連結部4の頂部41より刺入部2の先端21側に曲率半径0.25mmの凹みを有するステープルを作製した。図9(A)は作製したステープルの写真である。
[Puncture experiment]
<Example 6>
An alloy wire having a wire diameter of 0.25 mm obtained by the same procedure as in Examples 1 to 5 is pressed to 3 mm (distance connecting the boundary 24 between the left and right insertion portions 2 and the connecting portion 4) ×. It was processed into a staple shape of 2.5 mm (the length from the insertion portion 2 to the top 41 of the connecting portion 4). The tip of the staple insertion portion 2 was tapered at an angle of 45 degrees toward the inside of the staple with respect to the insertion direction. The radius of curvature of the connecting portion 4 was set to 0.5 mm. The length of the erection portion 3 was 2.5 mm. Next, by pressing a stainless steel rod having a diameter of 0.5 mm against the erection portion 3 of the processed staple, the erection portion 4 has a radius of curvature of 0.25 mm from the top 41 of the connecting portion 4 to the tip 21 side of the insertion portion 2. A staple having a dent was prepared. FIG. 9A is a photograph of the staples produced.

次に、作製したステープルを、豚肉を詰めた腸管に穿刺した。図9(C)は、腸管に穿刺したステープルの写真である。 Next, the prepared staples were punctured into the intestinal tract filled with pork. FIG. 9C is a photograph of staples punctured in the intestinal tract.

<比較例1>
実施例6において、直径0.5mmのステンレス製棒をステープルの架設部3に押付けず、プレス加工した状態のステープルを比較例1とした以外は、実施例6と同様に腸管に穿刺した。図9(B)は比較例1のステープルの写真、図9(D)は腸管に穿刺したステープルの写真である。
<Comparative example 1>
In Example 6, a stainless steel rod having a diameter of 0.5 mm was not pressed against the erection portion 3 of the staples, and the staples in a pressed state were used as Comparative Example 1, and the staples were punctured in the same manner as in Example 6. FIG. 9B is a photograph of the staple of Comparative Example 1, and FIG. 9D is a photograph of the staple punctured in the intestinal tract.

図9(A)〜(D)から明らかなように、架設部が連結部頂部より刺入部先端側に位置するステープルは、縫合箇所に密着していることが確認された。一方、比較例1のステープルは連結部で止まり、架設部が縫合箇所に密着するに至らなかった。
以上の結果より、ステープルの連結部が屈曲点を有しない湾曲部を含む形状に形成されると、生体内で破断し難くなり、更に、連結部の頂部と頂部を結んだ線より架設部の少なくとも一部が刺入部の先端側に位置することで、縫合箇所を長期間にわたり密着できることが明らかとなった。
As is clear from FIGS. 9A to 9D, it was confirmed that the staples in which the erection portion is located on the tip end side of the insertion portion from the top of the connecting portion are in close contact with the sutured portion. On the other hand, the staple of Comparative Example 1 stopped at the connecting portion, and the erection portion did not come into close contact with the sutured portion.
From the above results, if the connecting portion of the staple is formed into a shape including a curved portion having no bending point, it becomes difficult to break in the living body, and further, the erection portion is formed from a line connecting the tops of the connecting portions. It was clarified that the sutured portion can be adhered for a long period of time by locating at least a part on the tip side of the insertion portion.

[動物体内での縫合実験]
<実施例7>
実施例1の原料に代え、マグネシウム(Mg)、レアアース(RE;Ndを主成分とするミッシュメタル)、イットリウム(Y)を、重量%で96%Mg−3.0%RE−1.0%Yとなるように用いた以外は、実施例1と同様の手順で合金線材を作製し、次いで、線径0.25mmの線材を、プレス加工により3mm(左右の刺入部2と連結部4の境界24を結んだ距離)×2.5mm(刺入部2と連結部4の頂部41までの長さ)のステープル形状に加工した。ステープルの刺入部2の先端は、刺入方向に対しステープル内側に向かって45度の角度でテーパー加工を施した。
次に、作製したステープルを用い、以下の手順により動物体内で縫合を行い病理所見の検討を行った。
(1)全身麻酔下で豚3頭を開腹し、回腸末端から50cmの部位を縫合器(エチコン(ジョンソン・エンド・ジョンソン)社製;Powered ECHELON FLEX)を用いて小腸機械縫合した。
(2)術後、1週間、2週間、4週間飼育した後開腹し、縫合部周囲の病理所見を観察した。病理所見は、縫合部の周囲の肉眼観察と、HE染色により観察した。HE染色は、以下の手順で行った。
(a)研磨標本を脱樹脂後、水洗した。
(b)ワイゲルト鉄ヘマトキシリン液に60分浸漬した。
(c)水洗後、エオジン液に7分浸漬した。
(d)エタノールで脱水し、キシレンで透徹後、封入した。
[Suture experiment in animal body]
<Example 7>
Instead of the raw materials of Example 1, magnesium (Mg), rare earth (RE; misch metal containing Nd as a main component), and yttrium (Y) were added in 96% by weight% Mg-3.0% RE-1.0%. An alloy wire rod was produced in the same procedure as in Example 1 except that it was used so as to be Y, and then a wire rod having a wire diameter of 0.25 mm was pressed to 3 mm (left and right insertion portions 2 and connecting portion 4). It was processed into a staple shape of (distance connecting the boundaries 24) x 2.5 mm (the length from the insertion portion 2 to the top 41 of the connecting portion 4). The tip of the staple insertion portion 2 was tapered at an angle of 45 degrees toward the inside of the staple with respect to the insertion direction.
Next, using the prepared staples, the staples were sutured in the animal body according to the following procedure to examine the pathological findings.
(1) Three pigs were laparotomized under general anesthesia, and a site 50 cm from the terminal ileum was sutured mechanically in the small intestine using a suture device (manufactured by Ethicon (Johnson &Johnson); Powered ECHELON FLEX).
(2) After the operation, the animals were bred for 1 week, 2 weeks, and 4 weeks, and then the abdomen was opened, and the pathological findings around the sutured part were observed. Pathological findings were observed by macroscopic observation around the sutured part and HE staining. HE staining was performed by the following procedure.
(A) The polished specimen was deresined and then washed with water.
(B) Immersed in Weigert iron hematoxylin solution for 60 minutes.
(C) After washing with water, it was immersed in an eosin solution for 7 minutes.
(D) Dehydrated with ethanol, permeable with xylene, and then sealed.

図10(A)は術後1週間のHE染色した切片の写真(20倍拡大)、図10(B)は術後1週間のHE染色した切片の写真(200倍拡大)、図11(A)は術後2週間のHE染色した切片の写真(40倍拡大)、図11(B)は術後2週間のHE染色した切片の写真(100倍拡大)、図12(A)は術後4週間のHE染色した切片の写真(100倍拡大)、図12(B)は術後4週間のHE染色した切片の写真(400倍拡大)である。 FIG. 10 (A) is a photograph of the HE-stained section one week after the operation (20-fold magnification), FIG. 10 (B) is a photograph of the HE-stained section one week after the operation (200-fold magnification), and FIG. 11 (A). ) Is a photograph of a HE-stained section 2 weeks after surgery (40-fold magnification), FIG. 11 (B) is a photograph of a HE-stained section 2 weeks after surgery (100-fold magnification), and FIG. 12 (A) is postoperative. A 4-week HE-stained section photograph (100-fold magnification) and FIG. 12 (B) are a 4-week postoperative HE-stained section photograph (400-fold magnification).

<比較例2>
実施例7のステープルに代えチタン製ステープル(エチコン(ジョンソン・エンド・ジョンソン)社製;ECR45W)を用い、実施例7とずらした位置(胃幽門部から50cm)で小腸機械縫合した以外は実施例7と同時に小腸縫合を行った。病理所見の観察は、実施例7と同様の手順で行った。
<Comparative example 2>
Examples except that a titanium staple (manufactured by Ethicon (Johnson &Johnson); ECR45W) was used instead of the staple of Example 7 and the small intestine was mechanically sutured at a position shifted from Example 7 (50 cm from the gastric pylorus). At the same time as 7, the small intestine was sutured. The pathological findings were observed in the same procedure as in Example 7.

図10(C)は術後1週間のHE染色した切片の写真(20倍拡大)、図10(D)は術後1週間のHE染色した切片の写真(200倍拡大)、図11(C)は術後2週間のHE染色した切片の写真(40倍拡大)、図11(D)は術後2週間のHE染色した切片の写真(100倍拡大)、図12(C)は術後4週間のHE染色した切片の写真(100倍拡大)、図12(D)は術後4週間のHE染色した切片の写真(400倍拡大)である。 FIG. 10 (C) is a photograph of the HE-stained section one week after the operation (20-fold magnification), FIG. 10 (D) is a photograph of the HE-stained section one week after the operation (200-fold magnification), and FIG. 11 (C). ) Is a photograph of a HE-stained section 2 weeks after surgery (40-fold magnification), FIG. 11 (D) is a photograph of a HE-stained section 2 weeks after surgery (100-fold magnification), and FIG. 12 (C) is postoperative. A 4-week HE-stained section photograph (100-fold magnification) and FIG. 12 (D) are a 4-week postoperative HE-stained section photograph (400-fold magnification).

図10(A)〜(D)及び肉眼観察から、術後1週間の時点で以下の病理所見が得られた。
(a)実施例7(Mgステープル)及び比較例2(Tiステープル)とも金属周囲に炎症細胞浸潤を認めたが、その影響は比較的狭い範囲にとどまっていた。
(b)Mgステープル及びTiステープルとも金属周囲の炎症は粘膜から漿膜面へ及んでいた。炎症の度合いは同程度であった。
(c)Tiステープルの方が、金属を中心に好中球・好酸球・リンパ球による炎症波及が強かった。
From FIGS. 10 (A) to 10 (D) and macroscopic observation, the following pathological findings were obtained one week after the operation.
(A) Infiltration of inflammatory cells was observed around the metal in both Example 7 (Mg staple) and Comparative Example 2 (Ti staple), but the effect was limited to a relatively narrow range.
(B) Inflammation around the metal of both Mg staples and Ti staples extended from the mucosa to the serosal surface. The degree of inflammation was similar.
(C) Ti staples had a stronger inflammatory spread due to neutrophils, eosinophils, and lymphocytes, mainly in metals.

図11(A)〜(D)及び肉眼観察から、術後2週間の時点で以下の病理所見が得られた。
(d)Mgステープル及びTiステープルとも比較的強い炎症細胞浸潤を標本全体に認めた。金属片とある程度離れていてるところにも炎症の波及が認められた。
(e)Mgステープル及びTiステープルとも金属周囲の炎症は粘膜から漿膜面へ及んでいた。炎症の度合いは同程度であった。
(f)Tiステープルの方が、金属を中心に好中球・好酸球・リンパ球による炎症波及が強かった。
From FIGS. 11 (A) to 11 (D) and macroscopic observation, the following pathological findings were obtained 2 weeks after the operation.
(D) Relatively strong inflammatory cell infiltration was observed in both Mg staples and Ti staples throughout the specimen. Inflammation spread was also observed at some distance from the metal pieces.
(E) Inflammation around the metal of both Mg staples and Ti staples extended from the mucosa to the serosal surface. The degree of inflammation was similar.
(F) Ti staples had a stronger inflammatory spread due to neutrophils, eosinophils, and lymphocytes, mainly in metals.

図12(A)〜(D)及び肉眼観察から、術後4週間の時点で以下の病理所見が得られた。
(g)Mgステープル及びTiステープルとも同程度に比較的強い炎症細胞浸潤を標本全体に認めた。また、金属片とある程度離れていてるところにも炎症の波及が認められた。(h)Tiステープルの方が、金属を中心に好中球・好酸球・リンパ球による炎症波及が強かった。
From FIGS. 12 (A) to 12 (D) and macroscopic observation, the following pathological findings were obtained at 4 weeks after the operation.
(G) Both Mg staples and Ti staples showed relatively strong inflammatory cell infiltration throughout the specimen. Inflammation spread was also observed in places that were some distance from the metal pieces. (H) Ti staples had a stronger inflammatory spread due to neutrophils, eosinophils, and lymphocytes, mainly in metals.

実施例7及び比較例2より、Mgステープル及びTiステープルとも、術後1週間までは金属片の埋込に伴う局所の炎症性変化は、金属片のごく近傍(周囲のみ)に留まっており、炎症の度合いは両者で同程度であった。そして、術後4週間の間で、Mgステープル及びTiステープルとも、比較的強い炎症細胞浸潤を組織全体に認め、炎症は金属片から比較的離れたところにも認められた。しかしながら、Tiステープルと比較すると、Mgステープルの方が好中球・好酸球・リンパ球による炎症波及が弱いことが明らかとなった。以上の結果より、生体内に留置するステープルの材料として、生分解性金属材料の方が好ましいことを確認した。 From Example 7 and Comparative Example 2, in both Mg staples and Ti staples, the local inflammatory changes associated with the implantation of the metal pieces remained in the immediate vicinity (only around) of the metal pieces until one week after the operation. The degree of inflammation was similar in both cases. Then, within 4 weeks after the operation, relatively strong inflammatory cell infiltration was observed in both Mg staples and Ti staples in the whole tissue, and inflammation was also observed in a place relatively distant from the metal piece. However, it was clarified that the inflammatory spread by neutrophils, eosinophils and lymphocytes was weaker in Mg staples than in Ti staples. From the above results, it was confirmed that a biodegradable metal material is preferable as a staple material to be indwelled in a living body.

本願で開示する実施形態のステープルを用いると、縫合箇所を長期間にわたり密着することができる。したがって、医療機関における手術に有用である。 By using the staples of the embodiment disclosed in the present application, the stitched portions can be brought into close contact with each other for a long period of time. Therefore, it is useful for surgery in medical institutions.

Claims (4)

生分解性金属材料で形成したステープルであって、
前記ステープルは、生体組織に刺し込む2本の刺入部、縫合箇所を跨る架設部、前記刺入部と前記架設部を連結する連結部を含み、
前記連結部は、屈曲点を有しない湾曲部を含む形状に形成され、且つ、
前記連結部の頂部と頂部を結んだ線より、前記架設部の少なくとも一部が刺入部の先端側に位置し、
前記連結部のもっとも湾曲した部分が、曲率半径=0.275mm以上である生体吸収性ステープル。
Staples made of biodegradable metal material
The staple includes two insertion portions to be inserted into a living tissue, an erection portion straddling a sutured portion, and a connecting portion connecting the insertion portion and the erection portion.
The connecting portion is formed in a shape including a curved portion having no bending point, and
At least a part of the erection part is located on the tip side of the insertion part from the line connecting the tops of the connection part .
The most curved portion of the connecting portion is a bioabsorbable staple having a radius of curvature = 0.275 mm or more .
前記架設部の全てが、前記連結部の頂部と頂部を結んだ線より刺入部の先端側に位置する請求項1に記載の生体吸収性ステープル。 The bioabsorbable staple according to claim 1, wherein all of the erection portions are located on the tip end side of the insertion portion from the line connecting the top portions of the connection portion. 前記生分解性金属材料が、マグネシウムを主成分とする合金から選択される請求項1または2に記載の生体吸収性ステープル。 The bioabsorbable staple according to claim 1 or 2 , wherein the biodegradable metal material is selected from an alloy containing magnesium as a main component. 前記生分解性金属材料の周りが、生分解性樹脂でコーティングされている請求項1〜の何れか一項に記載の生体吸収性ステープル。


The bioabsorbable staple according to any one of claims 1 to 3 , wherein the biodegradable metal material is coated with a biodegradable resin.


JP2017544249A 2015-10-09 2016-10-07 Bioabsorbable staple Active JP6823321B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2015201232 2015-10-09
JP2015201232 2015-10-09
PCT/JP2016/080002 WO2017061616A1 (en) 2015-10-09 2016-10-07 Bioabsorbable staple

Publications (2)

Publication Number Publication Date
JPWO2017061616A1 JPWO2017061616A1 (en) 2018-08-09
JP6823321B2 true JP6823321B2 (en) 2021-02-03

Family

ID=58487922

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017544249A Active JP6823321B2 (en) 2015-10-09 2016-10-07 Bioabsorbable staple

Country Status (2)

Country Link
JP (1) JP6823321B2 (en)
WO (1) WO2017061616A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220031310A1 (en) * 2020-07-29 2022-02-03 Magstape Llc Biometallic Alloy Surgical Staples and Methods
JP2024518074A (en) * 2021-05-10 2024-04-24 シラグ・ゲーエムベーハー・インターナショナル Absorbable surgical staple with coating - Patents.com
US20220354490A1 (en) * 2021-05-10 2022-11-10 Cilag Gmbh International Absorbable surgical staple comprising at least two coatings

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356064A (en) * 1991-10-18 1994-10-18 United States Surgical Corporation Apparatus and method for applying surgical staples to attach an object to body tissue
US6767356B2 (en) * 2000-09-01 2004-07-27 Angiolink Corporation Advanced wound site management systems and methods
US7056330B2 (en) * 2002-05-31 2006-06-06 Ethicon Endo-Surgery, Inc. Method for applying tissue fastener
CA2600114A1 (en) * 2005-03-11 2006-09-21 Ahmad R. Hadba Absorbable surgical fasteners
US20060291981A1 (en) * 2005-06-02 2006-12-28 Viola Frank J Expandable backspan staple
AU2009239670B2 (en) * 2008-04-21 2013-11-14 Quickring Medical Technologies Ltd. Surgical stapling systems
US8186556B2 (en) * 2008-05-09 2012-05-29 Tyco Healthcare Group Lp Variable compression surgical fastener apparatus

Also Published As

Publication number Publication date
WO2017061616A1 (en) 2017-04-13
JPWO2017061616A1 (en) 2018-08-09

Similar Documents

Publication Publication Date Title
CN105925847B (en) A kind of biodegradable zinc-base metal material and the ureterectasia stent obtained using the material
JP6823321B2 (en) Bioabsorbable staple
Pogorielov et al. Magnesium-based biodegradable alloys: Degradation, application, and alloying elements
RU2754035C2 (en) Magnesium alloy, method for its production and use
EP2555689B1 (en) Bioabsorbable magnesium knots for securing surgical suture
US8268235B2 (en) Implant with a base body of a biocorrodible magnesium alloy
CN213076762U (en) Degradable metal anastomosis nail
ES2487631T3 (en) Biodegradable implantable medical device formed from a material based on superpure magnesium
US4602632A (en) Bio absorbable metal hemostatic clip
US8888842B2 (en) Implant made of a metallic material which can be resorbed by the body
US11589906B2 (en) Biodegradable, magnesium-containing bone screws, methods for their preparation and medical applications therefore
Sun et al. Translational status of biomedical Mg devices in China
Ikeo et al. Fabrication of a magnesium alloy with excellent ductility for biodegradable clips
JP6164675B2 (en) Biological soft tissue fixation device and manufacturing method thereof
JP2017501756A (en) Bioerodible magnesium alloy microstructure for internal prostheses
Gao et al. The mechanical property and corrosion resistance of Mg-Zn-Nd alloy fine wires in vitro and in vivo
WO2017113657A1 (en) Iron-based alloy absorbable and implantable medical device for internal fixation
WO2016094510A1 (en) ULTRAHIGH DUCTILITY, NOVEL Mg-Li BASED ALLOYS FOR BIOMEDICAL APPLICATIONS
CN108378929A (en) With locator markers and preparation method thereof made of degradable metal
WO2016145955A1 (en) Corrosion-resistant, high strength and ductility zn-fe-re zinc alloy degradable by human body and applications of the alloy
Zhang et al. A biodegradable magnesium surgical staple for colonic anastomosis: In vitro and in vivo evaluation
Huang et al. The design, development, and in vivo performance of intestinal anastomosis ring fabricated by magnesium‑zinc‑strontium alloy
CN108543118B (en) Magnesium alloy fixing screw capable of being degraded controllably in vivo
CN109811265B (en) Fe-Mn-Cu-C alloy and medical application thereof
CN111803721A (en) Degradable zinc alloy anastomosis instrument and preparation method thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20180220

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190830

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200713

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200908

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20201221

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20201225

R150 Certificate of patent or registration of utility model

Ref document number: 6823321

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250